Intervention
Pharmacogenomic Study
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownCarvedilol in Preventing Heart Failure in Childhood Cancer SurvivorsNCT02717507 · 2016-04-04
COMPLETEDEntinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast CancerNCT02453620 · 2016-02-12
ACTIVE_NOT_RECRUITINGPembrolizumab in Treating Patients With Malignant MesotheliomaNCT02399371 · 2015-03-31
COMPLETEDLapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast CancerNCT01281163 · 2011-01-01
TERMINATEDRO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By SurgeryNCT01071564 · 2009-11-01
TERMINATEDCommon conditions
Estrogen Receptor Negative2Malignant Solid Neoplasm2Progesterone Receptor Negative2Recurrent Breast Carcinoma2Stage IV Breast Cancer2Anatomic Stage III Breast Cancer AJCC v81Anatomic Stage IV Breast Cancer AJCC v81Biphasic Mesothelioma1Breast Adenocarcinoma1Epithelioid Mesothelioma1Estrogen Receptor Positive1Hematopoietic and Lymphoid Cell Neoplasm1HER2/Neu Negative1HER2/Neu Positive1Invasive Breast Carcinoma1Peritoneal Malignant Mesothelioma1Pleural Biphasic Mesothelioma1Pleural Epithelioid Mesothelioma1Pleural Malignant Mesothelioma1Pleural Sarcomatoid Mesothelioma1Progesterone Receptor Positive1Recurrent Peritoneal Malignant Mesothelioma1Recurrent Pleural Malignant Mesothelioma1Sarcomatoid Mesothelioma1Stage IIIB Breast Cancer1
Leading sponsors
Trial status mix
COMPLETED2
TERMINATED2
ACTIVE_NOT_RECRUITING1
Phase mix
PHASE13
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.